drugset / Trial / NCT02561468

The Preemptive Analgesic Efficacy of Nefopam

NCT02561468

RandomizedParallel-groupDouble-blindPrevention

Summary

Nefopam is administered as a preemptive analgesic drug to the patient undergoing breast cancer surgery. It will be evaluated whether postoperative acute and chronic pain can be reduced.

Timeline

Start
2015-04
Primary completion
2016-01
Completion
2016-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Nefopam Small molecule 20 mg

Indications